Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655081 · ClinicalTrials.gov registry record · Phase 2
Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT02655081 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 48 participants.
The verdict
NCT02655081, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
To provide patients with bladder cancer who are scheduled to undergo radical cystectomy with a preoperative high-arginine nutritional supplement. The investigator will measure patient adherence to the regimen, tolerability of the supplement and feasibility of supplementation. Secondary outcome measures will include differences in length of stay and complication rate between groups.
Interventions
- DIETARY_SUPPLEMENT high arginine nutritional supplement (Nestle's Impact AR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02655081
The ClinicalTrials.gov registry entry for NCT02655081 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which high arginine nutritional supplement (Nestle's Impact AR) is the first listed.
NCT02655081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02655081 about?
NCT02655081 is a clinical study titled "Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy". To provide patients with bladder cancer who are scheduled to undergo radical cystectomy with a preoperative high-arginine nutritional supplement. The investigator will measure patient adherence to the regimen, tolerability of the supplement and feasibility of supplementation. Secondary outcome measu...
What is the current status of trial NCT02655081?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2015-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02655081?
The interventions under investigation include: high arginine nutritional supplement (Nestle's Impact AR) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02655081?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.